A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 97,088 shares of BAX stock, worth $2.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
97,088
Previous 94,890 2.32%
Holding current value
$2.86 Million
Previous $3.17 Million 16.13%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$32.85 - $40.26 $72,204 - $88,491
2,198 Added 2.32%
97,088 $3.69 Million
Q2 2024

Jul 19, 2024

BUY
$32.87 - $43.55 $794,369 - $1.05 Million
24,167 Added 34.17%
94,890 $3.17 Million
Q1 2024

Apr 22, 2024

BUY
$37.88 - $43.77 $472,590 - $546,074
12,476 Added 21.42%
70,723 $3.02 Million
Q4 2023

Jan 16, 2024

SELL
$31.71 - $38.95 $103,469 - $127,093
-3,263 Reduced 5.3%
58,247 $2.25 Million
Q3 2023

Oct 24, 2023

SELL
$37.32 - $49.29 $58,256 - $76,941
-1,561 Reduced 2.47%
61,510 $2.32 Million
Q2 2023

Jul 25, 2023

SELL
$39.98 - $47.68 $318,080 - $379,342
-7,956 Reduced 11.2%
63,071 $2.87 Million
Q1 2023

Apr 14, 2023

BUY
$37.58 - $52.57 $23,149 - $32,383
616 Added 0.87%
71,027 $2.88 Million
Q4 2022

Feb 08, 2023

SELL
$49.7 - $57.71 $798,082 - $926,707
-16,058 Reduced 18.57%
70,411 $3.59 Million
Q3 2022

Oct 25, 2022

SELL
$53.86 - $66.8 $399,371 - $495,322
-7,415 Reduced 7.9%
86,469 $4.66 Million
Q2 2022

Aug 12, 2022

BUY
$63.83 - $80.0 $310,341 - $388,960
4,862 Added 5.46%
93,884 $6.03 Million
Q1 2022

May 11, 2022

BUY
$76.85 - $89.45 $871,094 - $1.01 Million
11,335 Added 14.59%
89,022 $6.9 Million
Q4 2021

Feb 08, 2022

SELL
$74.57 - $87.19 $382,767 - $447,546
-5,133 Reduced 6.2%
77,687 $6.67 Million
Q3 2021

Nov 02, 2021

BUY
$73.77 - $83.61 $200,433 - $227,168
2,717 Added 3.39%
82,820 $6.66 Million
Q2 2021

Aug 11, 2021

BUY
$80.5 - $88.01 $123,970 - $135,535
1,540 Added 1.96%
80,103 $6.45 Million
Q1 2021

May 14, 2021

BUY
$76.38 - $86.03 $90,663 - $102,117
1,187 Added 1.53%
78,563 $6.63 Million
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $354,031 - $386,762
4,696 Added 6.46%
77,376 $6.21 Million
Q3 2020

Nov 04, 2020

SELL
$78.33 - $90.73 $23,107 - $26,765
-295 Reduced 0.4%
72,680 $5.85 Million
Q2 2020

Jul 17, 2020

SELL
$78.66 - $94.14 $104,932 - $125,582
-1,334 Reduced 1.8%
72,975 $6.28 Million
Q1 2020

Apr 21, 2020

SELL
$71.57 - $93.3 $2.43 Million - $3.16 Million
-33,891 Reduced 31.32%
74,309 $6.03 Million
Q4 2019

Feb 12, 2020

SELL
$76.7 - $88.45 $428,139 - $493,727
-5,582 Reduced 4.91%
108,200 $9.05 Million
Q3 2019

Nov 07, 2019

BUY
$81.4 - $89.78 $930,157 - $1.03 Million
11,427 Added 11.16%
113,782 $9.95 Million
Q2 2019

Aug 06, 2019

BUY
$73.44 - $82.41 $205,632 - $230,748
2,800 Added 2.81%
102,355 $8.38 Million
Q1 2019

May 06, 2019

BUY
$64.48 - $81.31 $147,723 - $186,281
2,291 Added 2.36%
99,555 $8.1 Million
Q4 2018

Feb 11, 2019

BUY
$61.45 - $77.8 $103,543 - $131,093
1,685 Added 1.76%
97,264 $6.4 Million
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $191,341 - $210,391
2,706 Added 2.91%
95,579 $7.37 Million
Q2 2018

Jul 30, 2018

SELL
$63.43 - $75.41 $1.18 Million - $1.41 Million
-18,668 Reduced 16.74%
92,873 $6.86 Million
Q1 2018

Apr 16, 2018

BUY
$62.56 - $72.26 $1.16 Million - $1.34 Million
18,564 Added 19.97%
111,541 $7.26 Million
Q4 2017

Feb 09, 2018

SELL
$61.45 - $66.05 $121,363 - $130,448
-1,975 Reduced 2.08%
92,977 $6.01 Million
Q3 2017

Oct 26, 2017

SELL
$59.5 - $64.61 $83,062 - $90,195
-1,396 Reduced 1.45%
94,952 $5.96 Million
Q2 2017

Aug 15, 2017

BUY
N/A
96,348
96,348 $5.83 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.